Andrew J. Dunning - Concepedia

Concepedia

Author

Andrew J. Dunning

Sanofi (United States)ORCID

Also Known As

A. Dunning, A. J. Dunning, Andrew Dunning, Andrew J Dunning, Andrew J. Dunning

29

Publications

1.8K

Citations

15

H-Index

21

Concepts

All Affiliations

Sanofi (United States)Vanderbilt University Medical Center University of Pittsburgh Sanofi (France)Pearl River Community College

AJ

About

Andrew J. Dunning is an author at Sanofi (United States) specializing in medicine, vaccination, and vaccine safety.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	409
2	Public Health	3	3	309
3	Epidemiology	3	3	262
4	Emergency Medicine	1	1	25
5	Geriatrics	1	1	94

Andrew J. Dunning

×

15

Publications

1.8K

Citations

15

H-Index

	Year	Citations
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults Carlos A. DiazGranados, Andrew J. Dunning, Murray Kimmel, New England Journal of Medicine	2014	820
Correlation of Cellular Immune Responses with Protection against Culture-Confirmed Influenza Virus in Young Children Bruce D. Forrest, Michael W. Pride, Andrew J. Dunning, Clinical and Vaccine Immunology	2008	251
High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009–2010 season Carlos A. DiazGranados, Andrew J. Dunning, Emilia Jordanov, Vaccine VaccinologyVaccine SafetyVaccinationPreventive MedicineElderly Adults	2012	122
Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines Carlos A. DiazGranados, Corwin A. Robertson, H. Keipp Talbot, Vaccine	2015	112
Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial Andrew J. Dunning, Carlos A. DiazGranados, Timothy Voloshen, Clinical and Vaccine Immunology VaccinationVaccine SafetyCross-protectionHigher TiterPreventive Medicine	2016	94
Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older Pierre J.T. De Villiers, A. Duncan Steele, L.A. Hiemstra, Vaccine VaccinationVaccine SafetyPreventive MedicineAdults 60Vaccine Efficacy	2009	93
Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty Carlos A. DiazGranados, Andrew J. Dunning, Corwin A. Robertson, Vaccine	2015	83
A model for immunological correlates of protection Andrew J. Dunning Statistics in Medicine VaccinationVaccine SafetyInfectious Disease EpidemiologyInfectious Disease ModellingHumoral Response	2005	75
Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older Adults Carlos A. DiazGranados, Andrew J. Dunning, Corwin A. Robertson, Clinical Infectious Diseases	2016	39
Some extensions in continuous models for immunological correlates of protection Andrew J. Dunning, Jennifer L. K. Kensler, Laurent Coudeville, BMC Medical Research Methodology	2015	33

Page 1